Announcements Trials
Browse Landscape

Phase

Phase 2 8Phase NA 4Phase 1/2 4Phase 1 2Phase 4 1Phase 3 1Phase 2/3 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Breast Neoplasms 33Carcinoma, Hepatocellular 27Neoplasms 19Colorectal Neoplasms 18Carcinoma, Non-Small-Cell Lung 16Stomach Neoplasms 15Leukemia, Myeloid, Acute 15Prostatic Neoplasms 12Lung Neoplasms 12Colonic Neoplasms 12Precursor Cell Lymphoblastic Leukemia-Lymphoma 11Rectal Neoplasms 10Neoplasm Metastasis 8Leukemia 8Pancreatic Neoplasms 7NSCLC 6Multiple Myeloma 6Liver Neoplasms 6Esophageal Neoplasms 6Glioblastoma 5Small Cell Lung Carcinoma 4Recurrence 4Polycystic Ovary Syndrome 4Nasopharyngeal Carcinoma 4Melanoma 4Lymphoma, Large B-Cell, Diffuse 4Head and Neck Neoplasms 4Gestational Trophoblastic Disease 4Esophageal Squamous Cell Carcinoma 4Cholangiocarcinoma 4

Interventions

Methotrexate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2/3 × Unknown × Drug-Related Side Effects and Adverse Reactions × Clear all
NCT03885388 2019-03-21

Combination of Methotrexate(MTX) and Actinomycin(ACTD) in the Low Risk Gestational Trophoblastic Neoplasma (GTN) Patients With Score of 5-6

Women's Hospital School Of Medicine Zhejiang University

Phase 2/3 Unknown
300 enrolled
Gynecologic

Gestational Trophoblastic Disease, Drug-Related Side Effects and Adverse Reactions

Data powered by HemOnc (CC BY 4.0) Colophon âš¡